title: E2A is a transcriptional regulator of CD38 expression in chronic lymphocytic leukemia.
abstract: CD38, a nucleotide-metabolizing ectoenzyme and a receptor, is a negative prognostic marker for chronic lymphocytic leukemia (CLL) patients. CD38 has a genetic polymorphism, with a C → G variation in a putative E-box located in a regulatory region. E2A, the predominant E-box factor in B lymphocytes, was found to be highly expressed by CD38(+) CLL patients. The highest CD38 levels scored by E2A(+)/G carrier patients suggested that E2A is (i) directly associated with CD38 expression, and that (ii) the binding of the transcription factor is influenced by the CD38 genotype. Chromatin immunoprecipitation indicated that E2A directly interacts with the CD38 regulatory region. Furthermore, E2A binding was stronger in the presence of the G allele. Experiments of E2A silencing led to a significant reduction of surface levels of CD38, confirming the working hypothesis. A direct functional interplay between E2A and CD38 was shown by exposing CLL cells to interleukin-2 and TLR-9 ligands, both inducers of CD38 expression. Under these conditions, CD38 upregulation was primarily conditioned by the presence of E2A and then by the G allele. The results of this study link E2A and CD38 expression within a common pathway, in which E-protein activity is required for the efficient induction of CD38 transcription.
authors.affiliation: Laboratory of Immunogenetics, Department of Genetics, Biology and Biochemistry, University of Turin Medical School, Turin, Italy.
authors.forename: I
authors.initials: I
authors.lastname: Saborit-Villarroya
authors.forename: T
authors.initials: T
authors.lastname: Vaisitti
authors.forename: D
authors.initials: D
authors.lastname: Rossi
authors.forename: G
authors.initials: G
authors.lastname: D'Arena
authors.forename: G
authors.initials: G
authors.lastname: Gaidano
authors.forename: F
authors.initials: F
authors.lastname: Malavasi
authors.forename: S
authors.initials: S
authors.lastname: Deaglio
mesh_terms: D051997:ADP-ribosyl Cyclase 1 / Q000235:genetics*; D051792:Basic Helix-Loop-Helix Proteins / Q000037:antagonists & inhibitors / Q000502:physiology*; D002478:Cells, Cultured; D015973:Gene Expression Regulation, Leukemic; D006801:Humans; D015451:Leukemia, Lymphocytic, Chronic, B-Cell / Q000235:genetics / Q000378:metabolism*; D008562:Membrane Glycoproteins / Q000235:genetics*; D014158:Transcription, Genetic
chemical_list: D051997:ADP-ribosyl Cyclase 1; D051792:Basic Helix-Loop-Helix Proteins; D008562:Membrane Glycoproteins; C407909:TCF3 protein, human; C498154:CD38 protein, human